by Pharmaguapa | Dec 1, 2020 | Autoimmune Disease, General, hashimoto's, Leadership
As we near the end of this second lockdown I find myself reflecting on my lockdown experience. I have heard from quite a few friends that they have found this second lockdown even harder than the first. Many people I know have struggled with mental health and...
by Pharmaguapa | Nov 12, 2020 | General, Patient centric, Social Media
Last week I read in an article that 72% of patients do not feel listened to by pharma. This is a very sorry state of affairs, but sadly does not surprise me. Whilst patients are the end users they are not seen as customers. Traditionally patients have not had a say...
by Pharmaguapa | Aug 31, 2020 | Business Process, General, marketing, Multichannel, Strategy
The other day I read an interesting article about how medical simulation needed to catch up to consumer gaming. It talked about how many medical simulators use outdated technology and approaches. They “look like something out of 1992”. This made me...
by Pharmaguapa | Aug 18, 2020 | General
I recently got back from an amazing holiday in the Azores and am a little bemused that I have to isolate for 14 days upon my return. Now do not get me wrong – I am a huge advocate for playing it safe and for isolating new arrivals to the country. Living in a...
by Pharmaguapa | Jul 7, 2020 | General, Leadership, marketing, Multichannel, Strategy
Living in a shielding household I have had a particularly locked-down few months, with no trips to any supermarkets or shops. I have had to rely entirely on the internet, and telephone, to access goods. During this time there have been some brands that have stood by...
by Pharmaguapa | Jun 19, 2020 | Business Process, General, Leadership, Multichannel, Reverse Mentoring, Strategy
We are currently living in what might be termed “interesting times”. We have seen our world turned upside down and huge changes happen in a very short period of time. The new normal has changed from face to face to virtual. Everything from meetings, to...
